Myovant
Oct 01, 2020
Brain’s immune cells research update; Moderna’s COVID-19 vaccine; Pfizer funnels $200 M into CStone; Myovant’s relugolix falls short in metastatic prostate cancer; Alnylam’s lumasiran phase 3 result
The immune cells of the brain could treat neurodegenerative diseases Human behavior relies on the stimulation and inhibition of neurons, and scientists have long considered that neurons are mainly responsible for maintaining this circuit of activity in balance. However, now, a research team led by the Icahn Scho...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
